Exosens
EXENS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €986,705 | €607,747 | €607,747 | €607,747 |
| - Cash | €117,200 | €15,458 | €28,955 | €15,927 |
| + Debt | €10,900 | €311,767 | €255,275 | €208,113 |
| Enterprise Value | €880,405 | €904,056 | €834,067 | €799,933 |
| Revenue | €394,100 | €318,796 | €200,751 | €166,168 |
| % Growth | 23.6% | 58.8% | 20.8% | – |
| Gross Profit | €225,600 | €176,809 | €113,952 | €100,034 |
| % Margin | 57.2% | 55.5% | 56.8% | 60.2% |
| EBITDA | €115,200 | €83,909 | €51,247 | -€101,178 |
| % Margin | 29.2% | 26.3% | 25.5% | -60.9% |
| Net Income | €30,700 | €17,140 | €11,212 | -€148,965 |
| % Margin | 7.8% | 5.4% | 5.6% | -89.6% |
| EPS Diluted | 0.6 | 0.56 | 0.37 | -4.9 |
| % Growth | 7.1% | 51.4% | 107.6% | – |
| Operating Cash Flow | €96,200 | €50,464 | €47,484 | €42,655 |
| Capital Expenditures | -€41,259 | -€30,938 | -€21,798 | -€19,587 |
| Free Cash Flow | €96,200 | €19,526 | €25,686 | €23,068 |